scispace - formally typeset
Open AccessJournal ArticleDOI

Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis

TLDR
MR imaging-PDFF showed promise for assessment of hepatic steatosis grade in patients with NAFLD, and was significantly correlated with histologic steatotic grade.
Abstract
MR imaging with proton density fat fraction (PDFF) permitted high overall accuracy with moderate sensitivity and high specificity for classification of dichotomized steatosis grade, and these results support the conduct of further studies to help validate MR imaging–PDFF as a biomarker of hepatic steatosis in nonalcoholic fatty liver disease.

read more

Citations
More filters
Journal ArticleDOI

Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease

TL;DR: Pancreas and vertebral body MRI-PDFF is well correlated in NAFLD patients and both of them are higher in diabetic patients which may explain increased bone fractures in diabetics.
Journal ArticleDOI

Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard

TL;DR: Investigating the diagnostic performance of 2-D ultrasound attenuation imaging for the assessment of hepatic steatosis in patients with chronic liver disease using magnetic resonance imaging proton density fat fraction as the reference standard found attenuation coefficients at ATI were well correlated with MRI-PDFF and, thus, may provide good diagnostic performance.
Journal ArticleDOI

Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease.

TL;DR: Current data suggest that ultrasound and the fibrosis-4 score are probably the most appealing methods for detecting Steatosis and for distinguishing NASH from simple steatosis, respectively, because of their low cost and relatively high accuracy.
Journal ArticleDOI

Hepatic Steatosis: Etiology, Patterns, and Quantification

TL;DR: Hepatic steatosis can occur because of nonalcoholic fatty liver disease (NAFLD), alcoholism, chemotherapy, and metabolic, toxic, and infectious causes, and Magnetic resonance (MR) elastography and functional evaluation with Gd-EOB-DTPA are becoming important for monitoring this process.
Journal ArticleDOI

Quantitative Imaging Biomarkers of NAFLD

TL;DR: The utility and limitation of conventional US, CT, and MR imaging for the diagnosis of nonalcoholic fatty liver disease are reviewed and recent advances in imaging biomarkers of NAFLD are discussed with an emphasis in multi-parametric quantitative MRI.
References
More filters
Journal ArticleDOI

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

TL;DR: There are no systems for grading necroinflammatory activity or for staging fibrosis as exist for various other forms of chronic liver disease and this study proposes a grading and staging system that reflects the unique histological features of nonalcoholic steatohepatitis.
Journal ArticleDOI

Sampling variability of liver fibrosis in chronic hepatitis C.

TL;DR: It is suggested that a length of at least 25 mm is necessary to evaluate fibrosis accurately with a semiquantitative score, because variability in the distribution of fibrosis within the liver is a major limitation when using more accurate methods such as automated image analysis.
Journal ArticleDOI

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

TL;DR: Histologic lesions of NASH are unevenly distributed throughout the liver parenchyma; therefore, sampling error of liver biopsy can result in substantial misdiagnosis and staging inaccuracies.
Related Papers (5)